Publicaciones en las que colabora con ANA ISABEL SÁNCHEZ FRUCTUOSO (61)

2016

  1. Serum biomarkers in uncontrolled no heart-beating donors may identify kidneys that will never work after transplantation

    Journal of Nephrology, Vol. 29, Núm. 1, pp. 119-127

2012

  1. Everolimus as primary immunosuppression in kidney transplantation: Experience in conversion from calcineurin inhibitors

    Transplantation, Vol. 93, Núm. 4, pp. 398-405

  2. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation

    Transplantation Proceedings

  3. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients

    Nephrology Dialysis Transplantation, Vol. 27, Núm. 11, pp. 4227-4235

2011

  1. Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients

    Transplant Infectious Disease, Vol. 13, Núm. 6, pp. 584-591

2010

  1. H1N1 2009 influenza in kidney transplant patients

    Transplantation

  2. Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 2902-2904

2009

  1. Graft Outcome and Mycophenolic Acid Trough Level Monitoring in Kidney Transplantation

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2102-2103

  2. Inadequate Mycophenolic Acid Exposure and Acute Rejection in Kidney Transplantation

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2104-2105

  3. Intracellular ATP Levels in CD4+ Lymphocytes Are a Risk Marker of Rejection and Infection in Renal Graft Recipients

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2106-2108

  4. Sirolimus and Everolimus Induced Pneumonitis in Adult Renal Allograft Recipients: Experience in a Center

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2163-2165

  5. The Prevalence of Uridine Diphosphate-Glucuronosyltransferase 1A9 (UGT1A9) Gene Promoter Region Single-Nucleotide Polymorphisms T-275A and C-2152T and Its Influence on Mycophenolic Acid Pharmacokinetics in Stable Renal Transplant Patients

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2313-2316

2007

  1. Better Mycophenolic Acid 12-Hour Trough Level After Enteric-Coated Mycophenolate Sodium in Patients With Gastrointestinal Intolerance to Mycophenolate Mofetil

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2194-2196

  2. Effect of the Brain-Death Process on Acute Rejection in Renal Transplantation

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2214-2216

  3. Evaluation of the Efficacy and Safety of the Conversion From a Calcineurin Inhibitor to an Everolimus-Based Therapy in Maintenance Renal Transplant Patients

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2148-2150

  4. Histologic Assessment of Donor Kidneys and Graft Outcome: Multivariate Analyses

    Transplantation Proceedings, Vol. 39, Núm. 5, pp. 1368-1370

  5. Kidney transplantation from non-heart-beating donors: a Spanish view

    Transplantation Reviews, Vol. 21, Núm. 4, pp. 249-254

  6. Preemptive Kidney Transplant From Deceased Donors: An Advantage in Relation to Reduced Waiting List

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2123-2124

  7. Study of Anemia After Late Introduction of Everolimus in the Immunosuppressive Treatment of Renal Transplant Patients

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2242-2244

2006

  1. Conversion to Everolimus in Kidney Transplant Recipients: A Safe and Simple Procedure

    Transplantation Proceedings, Vol. 38, Núm. 8, pp. 2424-2426